4/19
07:16 am
prqr
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio [Yahoo! Finance]
Medium
Report
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio [Yahoo! Finance]
4/19
07:00 am
prqr
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Medium
Report
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
4/18
12:05 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc. from $1.80 to $2.00. They now have a "buy" rating on the stock.
Medium
Report
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc. from $1.80 to $2.00. They now have a "buy" rating on the stock.
3/19
02:09 am
prqr
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/18
03:10 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Chardan Capital from $2.00 to $2.50. They now have a "buy" rating on the stock.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Chardan Capital from $2.00 to $2.50. They now have a "buy" rating on the stock.
3/18
03:10 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
3/13
07:00 am
prqr
ProQR Announces Year End 2023 Operating and Financial Results
High
Report
ProQR Announces Year End 2023 Operating and Financial Results
3/11
11:00 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/11
11:00 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/28
11:06 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/15
07:12 am
prqr
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing [Yahoo! Finance]
Low
Report
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing [Yahoo! Finance]
2/15
07:00 am
prqr
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
Low
Report
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
2/12
10:05 pm
prqr
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/2
01:05 am
prqr
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
1/25
01:08 am
prqr
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.